In re Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation

Consumer ProtectionOngoing
Written By Alex Lezberg

STATUS — Ongoing

PRACTICE — Consumer Protection

CASE — MDL No. 3094, U.S. District Court for the Eastern District of Pennsylvania

FKB’s Roberta Liebenberg currently serves as liaison counsel for the plaintiffs in this consumer protection case. The plaintiffs allege they suffered gastrointestinal injury stemming from their use of glucagon-like peptide-1 receptor agonists, including Ozempic and Wegovy.

 
Alex Lezberg
Previous

In re Cathode Ray Tube (CRT) Antitrust Litigation
Next

In re Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Litigation